# SACHI (NCT05015608)

> Study on Savolitinib Combined With Osimertinib in Treatment of Advanced NSCLC With MET Amplification

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05015608
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Hutchison Medipharma Limited
- Conditions: Non-small Cell Lung Cancer
- Interventions: Savolitinib + Osimertinib; Pemetrexed + Cisplatin /Carboplatin
- Enrollment: 216
- Primary outcome: PFS

## Commentary we found

- X threads: 22
- Podcasts: 9
- YouTube: 7
- X videos: 1

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=sachi-nct05015608

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT05015608", "email": "<work email>"}; the inbox owner confirms by the emailed link.